By Iain Gilbert
Date: Monday 29 Jul 2019
(Sharecast News) - Generic pharmaceuticals maker Mylan shares shot up at the bell after posting a second-quarter revenue beat and agreeing to merge with Pfizer's off-patent unit.
By Iain Gilbert
Date: Wednesday 09 May 2018
(Sharecast News) - American speciality pharmaceuticals company Mylan reported a fall in revenue for first-quarter on Wednesday but upped its full year guidance.
By Iain Gilbert
Date: Wednesday 04 Oct 2017
(ShareCast News) - US-based generic and speciality pharmaceuticals company Mylan announced on Tuesday that the US Food and Drug Administration (FDA) had approved two doses of its generic equivalent to Teva's drug Copaxone, which generated $1.02bn worth of sales in the second quarter of 2017, used to treat relapsing forms of multiple sclerosis.
Currency | US Dollars |
Share Price | $ 0.00 |
Closing Price Change | $ 0.00 |
% Change | 0.00 % |
52 Week High | $0.00 |
52 Week Low | $0.00 |
Volume | 0 |
Shares Issued | 516.15m |
RiskGrade | 173 |
You are here: research